vs

Side-by-side financial comparison of PATHWARD FINANCIAL, INC. (CASH) and NEOGENOMICS INC (NEO). Click either name above to swap in a different company.

NEOGENOMICS INC is the larger business by last-quarter revenue ($186.7M vs $173.1M, roughly 1.1× PATHWARD FINANCIAL, INC.). PATHWARD FINANCIAL, INC. runs the higher net margin — 20.3% vs -57.9%, a 78.2% gap on every dollar of revenue. On growth, NEOGENOMICS INC posted the faster year-over-year revenue change (11.1% vs -0.2%). Over the past eight quarters, NEOGENOMICS INC's revenue compounded faster (6.5% CAGR vs -18.0%).

Pathward Financial, Inc. is a U.S.-based banking and financial services company. It adopted its current name in 2022 after its parent, Meta Financial Group, sold the "Meta" trademark to Meta Platforms.

NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization (FISH), flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics.

CASH vs NEO — Head-to-Head

Bigger by revenue
NEO
NEO
1.1× larger
NEO
$186.7M
$173.1M
CASH
Growing faster (revenue YoY)
NEO
NEO
+11.3% gap
NEO
11.1%
-0.2%
CASH
Higher net margin
CASH
CASH
78.2% more per $
CASH
20.3%
-57.9%
NEO
Faster 2-yr revenue CAGR
NEO
NEO
Annualised
NEO
6.5%
-18.0%
CASH

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
CASH
CASH
NEO
NEO
Revenue
$173.1M
$186.7M
Net Profit
$35.2M
$-108.0M
Gross Margin
43.3%
Operating Margin
24.6%
46.9%
Net Margin
20.3%
-57.9%
Revenue YoY
-0.2%
11.1%
Net Profit YoY
11.9%
42.0%
EPS (diluted)
$1.57
$-0.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CASH
CASH
NEO
NEO
Q1 26
$186.7M
Q4 25
$173.1M
$190.2M
Q3 25
$186.7M
$187.8M
Q2 25
$195.8M
$181.3M
Q1 25
$274.8M
$168.0M
Q4 24
$182.6M
$172.0M
Q3 24
$179.5M
$167.8M
Q2 24
$188.6M
$164.5M
Net Profit
CASH
CASH
NEO
NEO
Q1 26
$-108.0M
Q4 25
$35.2M
Q3 25
$38.8M
$-27.1M
Q2 25
$42.1M
$-45.1M
Q1 25
$75.0M
$-25.9M
Q4 24
$30.0M
Q3 24
$33.5M
$-17.7M
Q2 24
$44.9M
$-18.6M
Gross Margin
CASH
CASH
NEO
NEO
Q1 26
43.3%
Q4 25
43.8%
Q3 25
42.8%
Q2 25
42.6%
Q1 25
43.6%
Q4 24
44.9%
Q3 24
44.6%
Q2 24
44.1%
Operating Margin
CASH
CASH
NEO
NEO
Q1 26
46.9%
Q4 25
24.6%
-7.1%
Q3 25
25.9%
-14.4%
Q2 25
24.1%
-26.3%
Q1 25
33.2%
-16.6%
Q4 24
19.8%
-10.7%
Q3 24
20.9%
-12.6%
Q2 24
27.1%
-13.3%
Net Margin
CASH
CASH
NEO
NEO
Q1 26
-57.9%
Q4 25
20.3%
Q3 25
20.8%
-14.4%
Q2 25
21.5%
-24.9%
Q1 25
27.3%
-15.4%
Q4 24
16.4%
Q3 24
18.7%
-10.5%
Q2 24
23.8%
-11.3%
EPS (diluted)
CASH
CASH
NEO
NEO
Q1 26
$-0.13
Q4 25
$1.57
Q3 25
$1.69
Q2 25
$1.81
Q1 25
$3.14
Q4 24
$1.23
Q3 24
$1.34
Q2 24
$1.78

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CASH
CASH
NEO
NEO
Cash + ST InvestmentsLiquidity on hand
$331.2M
$146.1M
Total DebtLower is stronger
$33.5M
Stockholders' EquityBook value
$854.5M
$828.8M
Total Assets
$7.6B
$1.3B
Debt / EquityLower = less leverage
0.04×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CASH
CASH
NEO
NEO
Q1 26
$146.1M
Q4 25
$331.2M
$159.6M
Q3 25
$120.6M
$164.1M
Q2 25
$258.3M
$154.7M
Q1 25
$254.2M
$346.2M
Q4 24
$597.4M
$367.0M
Q3 24
$158.3M
$362.0M
Q2 24
$298.9M
$355.1M
Total Debt
CASH
CASH
NEO
NEO
Q1 26
Q4 25
$33.5M
$341.9M
Q3 25
$33.5M
Q2 25
$33.4M
Q1 25
$33.4M
Q4 24
$33.4M
$541.1M
Q3 24
$33.4M
Q2 24
$33.3M
Stockholders' Equity
CASH
CASH
NEO
NEO
Q1 26
$828.8M
Q4 25
$854.5M
$836.6M
Q3 25
$858.0M
$838.3M
Q2 25
$819.0M
$854.0M
Q1 25
$814.7M
$888.3M
Q4 24
$758.3M
$902.3M
Q3 24
$822.5M
$908.2M
Q2 24
$748.4M
$915.9M
Total Assets
CASH
CASH
NEO
NEO
Q1 26
$1.3B
Q4 25
$7.6B
$1.4B
Q3 25
$7.2B
$1.4B
Q2 25
$7.2B
$1.4B
Q1 25
$7.0B
$1.6B
Q4 24
$7.6B
$1.6B
Q3 24
$7.5B
$1.6B
Q2 24
$7.5B
$1.6B
Debt / Equity
CASH
CASH
NEO
NEO
Q1 26
Q4 25
0.04×
0.41×
Q3 25
0.04×
Q2 25
0.04×
Q1 25
0.04×
Q4 24
0.04×
0.60×
Q3 24
0.04×
Q2 24
0.04×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CASH
CASH
NEO
NEO
Operating Cash FlowLast quarter
$108.3M
$-8.1M
Free Cash FlowOCF − Capex
$104.1M
FCF MarginFCF / Revenue
60.1%
Capex IntensityCapex / Revenue
2.4%
Cash ConversionOCF / Net Profit
3.08×
TTM Free Cash FlowTrailing 4 quarters
$616.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CASH
CASH
NEO
NEO
Q1 26
$-8.1M
Q4 25
$108.3M
$1.3M
Q3 25
$303.7M
$8.9M
Q2 25
$30.4M
$20.3M
Q1 25
$188.3M
$-25.3M
Q4 24
$-71.7M
$9.8M
Q3 24
$143.1M
$9.2M
Q2 24
$113.2M
$13.9M
Free Cash Flow
CASH
CASH
NEO
NEO
Q1 26
Q4 25
$104.1M
$-6.5M
Q3 25
$300.3M
$570.0K
Q2 25
$27.7M
$14.0M
Q1 25
$184.7M
$-29.8M
Q4 24
$-73.8M
$-1.8M
Q3 24
$138.8M
$-1.6M
Q2 24
$111.0M
$814.0K
FCF Margin
CASH
CASH
NEO
NEO
Q1 26
Q4 25
60.1%
-3.4%
Q3 25
160.9%
0.3%
Q2 25
14.1%
7.7%
Q1 25
67.2%
-17.8%
Q4 24
-40.4%
-1.0%
Q3 24
77.3%
-0.9%
Q2 24
58.8%
0.5%
Capex Intensity
CASH
CASH
NEO
NEO
Q1 26
Q4 25
2.4%
4.1%
Q3 25
1.8%
4.4%
Q2 25
1.4%
3.5%
Q1 25
1.3%
2.7%
Q4 24
1.1%
6.7%
Q3 24
2.4%
6.4%
Q2 24
1.2%
8.0%
Cash Conversion
CASH
CASH
NEO
NEO
Q1 26
Q4 25
3.08×
Q3 25
7.83×
Q2 25
0.72×
Q1 25
2.51×
Q4 24
-2.39×
Q3 24
4.27×
Q2 24
2.52×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CASH
CASH

Consumer$103.0M59%
Payment Card And Deposit Fees$30.1M17%
Other$24.2M14%
Rental Income$11.6M7%
Commercial$4.2M2%

NEO
NEO

Segment breakdown not available.

Related Comparisons